SSRIs and Other Antidepressants

Prozac®, Zoloft®, Paxil
®, Luvox®, Celexa®, Effexor®, Wellbutrin®, and other antidepressants.

Rational Principles of Psychopharmacology (2016)

Breggin, PR. (2016). Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. J Contemp Psychother 46:1–13. Because the epidemic dispensing of psychiatric drugs is based on misinformation, it is important for all health professionals, consumers, and most citizens (including patients and their family members) to have a more rational understanding of how psychiatric drugs […]

Read More

Psychiatric drug-induced Chronic Brain Impairment (CBI) (2011)

Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication. International Journal of Risk & Safety in Medicine, 23: 193-200. Peter R. Breggin, MD Abstract: Understanding the hazards associated with long-term exposure to psychiatric drugs is very important but rarely emphasized in the scientific literature and clinical practice. Drawing on the scientific […]

Read More

Antidepressant-Induced Suicide, Violence, and Mania: Risks for Military Personnel (2010)

Ethical Human Psychology and Psychiatry, Volume 12, Number 2, 2010. Peter R. Breggin, MD The newer antidepressants frequently cause suicide, violence, and manic-like symptoms of activation or overstimulation, presenting serious hazards to active-duty soldiers who carry weapons under stressful conditions. These antidepressant-induced symptoms of activation can mimic posttraumatic stress disorder and are likely to worsen […]

Read More

Intoxication anosognosia: medication spellbinding (2006)

“Intoxication Anosognosia: The Spellbinding Effect of Psychiatric Drugs”, Ethical Human Psychology and Psychiatry, 8, 201-215, 2006. ABSTRACT: Why do so many individuals persist in taking psychoactive substances, including psychiatric drugs, after adverse mental and behavioral effects have become severe and even disabling? The author has previously proposed the brain-disabling principle of psychiatric treatment that all […]

Read More

Recent Regulatory Changes in Antidepressant Labels: Implicatons of Activation (2006)

More focus is needed on the risk of activation or stimulation as described in the new class of warnings from the Food and Drug Administration, including anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, mania and other unusual changes of behavior, worsening of depression and suicidal ideation. recentregulatory.pbreggin.2006.pdf

Read More